Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

D-Wave Quantum Inc. Director's Dealing 2025

May 23, 2025

30690_dirs_2025-05-23_7c305b85-14e8-4d99-a4a2-78da1b38794e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: D-Wave Quantum Inc. (QBTS)
CIK: 0001907982
Period of Report: 2025-05-21

Reporting Person: Markovich John M. (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-05-21 Common Stock, par value $0.0001 per share ("Common Stock") M 502702 $0.92 Acquired 1977944 Direct
2025-05-21 Common Stock, par value $0.0001 per share ("Common Stock") S 200000 $16.85 Disposed 1777944 Direct
2025-05-21 Common Stock, par value $0.0001 per share ("Common Stock") S 200000 $17.75 Disposed 1577944 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-05-21 Stock Option (right to buy) $0.92 M 502702 Disposed 2031-08-20 Common Stock, par value $0.0001 per share ("Common Stock") (502702) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $0.846 2034-01-10 Common Stock, par value $0.0001 per share ("Common Stock") (120826) 120826 Direct

Footnotes

F1: Includes 861,610 shares of unvested restricted stock units.

F2: The sales reported in this Form 4 were effected for financial and tax planning purposes.

F3: The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $16.70 to $17.00, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.

F4: The option has vested and is exercisable as of the date hereof as to 1,407,555 shares of Common Stock and the remaining portion of the option vests in equal monthly installments on the 20th of each month through August 20, 2025 as to 93,831 shares of Common Stock.

F5: This option has vested and is exercisable as of the grant date as to all 120,826 shares of Common Stock.